Pulmonary valve stenosis is a narrowing of the valve that sits between the right side of the heart and the arteries leading to the lungs. The valve’s flaps become thick, stiff, or fused together, which prevents the valve from opening fully. This forces the heart to work harder to push blood toward the lungs, and over time that extra effort can take a toll on the heart muscle itself.
Most cases are present from birth, and many people with mild forms live their entire lives without symptoms or treatment. When the narrowing is moderate to severe, though, it can cause noticeable problems and usually requires intervention.
How It Affects the Heart
The pulmonary valve normally has three thin flaps (called cusps) that open wide to let blood flow from the right ventricle into the pulmonary arteries and on to the lungs, where it picks up oxygen. In pulmonary valve stenosis, one or more of those flaps is thickened, stiffened, or stuck to its neighbor. The result is a smaller-than-normal opening.
Because the opening is restricted, pressure builds up inside the right ventricle. The heart muscle responds the way any muscle does when it’s asked to push harder: it gets thicker. This thickening, called right ventricular hypertrophy, is the body’s attempt to compensate. It works for a while, but sustained high pressure can eventually lead to right-sided heart strain, chamber dilation, and in rare cases, heart failure if the condition goes untreated for decades.
Symptoms to Recognize
Mild pulmonary valve stenosis often produces no symptoms at all. It may only be discovered when a doctor hears a heart murmur during a routine exam. As the narrowing becomes more significant, symptoms tend to appear during physical exertion first, then at rest in severe cases. Common signs include:
- Shortness of breath during exercise or activity
- Fatigue that seems out of proportion to the effort
- A heart murmur heard through a stethoscope
- Chest pain or a sensation of pressure
- Fainting or dizziness during exertion, in more severe cases
- Bluish skin (particularly in newborns with critical stenosis)
In newborns, critical pulmonary stenosis can be a medical emergency. The valve is so tight that very little blood reaches the lungs, and the baby may appear blue shortly after birth.
What Causes It
The vast majority of cases are congenital, meaning the valve develops abnormally during pregnancy. In most people, no single clear cause is identified. However, certain genetic syndromes significantly raise the risk.
Noonan syndrome is the condition most closely linked to pulmonary valve stenosis. It belongs to a family of genetic disorders called RASopathies, which affect a specific cell-signaling pathway involved in heart development. In one large genetic study of patients with the condition, the majority of those who received a molecular diagnosis had a RASopathy. A smaller number had variants in other genes involved in congenital heart development.
Some patients also have what’s called a dysplastic pulmonary valve, where the valve tissue is unusually thick and rubbery rather than simply fused. This type is especially common in people with Noonan syndrome and can be harder to treat with standard catheter-based techniques.
Acquired pulmonary valve stenosis, developing later in life rather than being present at birth, is rare. It can occasionally result from conditions that cause scarring or thickening of the valve, such as carcinoid heart disease, where tumors release substances that damage heart valve tissue.
How It’s Diagnosed
An echocardiogram is the primary tool for diagnosing pulmonary valve stenosis. This ultrasound of the heart shows the valve’s structure in real time and, critically, measures the pressure difference between the right ventricle and the pulmonary artery. That pressure gradient is what determines severity. A gradient of 40 to 60 mmHg indicates moderate stenosis, while anything above 60 mmHg is classified as severe.
An electrocardiogram (ECG) is usually done alongside the echocardiogram. It records the heart’s electrical activity and can reveal signs of right ventricular strain or thickening. In some cases, MRI or CT scans provide additional detail about the heart’s structure. Cardiac catheterization, where a thin tube is threaded through a blood vessel to the heart, is sometimes used both to confirm the diagnosis and to measure pressures directly. It also serves as the gateway to treatment, since the same catheter procedure can be used to open the valve.
Treatment Options
Mild pulmonary valve stenosis with a low pressure gradient typically doesn’t require treatment. Regular monitoring with periodic echocardiograms is usually enough, since many mild cases remain stable for life.
For moderate to severe stenosis, balloon valvuloplasty is the preferred first-line treatment. During this catheter-based procedure, a deflated balloon is guided through a vein to the narrowed valve and then inflated to stretch the valve open. It’s effective in the majority of patients, including newborns with critical stenosis, and avoids the need for open-heart surgery. The procedure is typically done under sedation, and most patients go home within a day or two.
Surgery becomes necessary when the valve is too thick or dysplastic for a balloon to work effectively, or when the valve needs to be replaced entirely. Surgical repair involves opening the fused valve flaps, while replacement substitutes a biological or mechanical valve. These scenarios are less common but important for patients whose valve anatomy doesn’t respond well to balloon treatment.
Long-Term Outlook
The long-term prognosis for pulmonary valve stenosis is generally excellent, especially when it’s treated early. Most people who undergo successful balloon valvuloplasty or surgery live normal, active lives. A longitudinal study following patients for 22 to 33 years after surgical repair found no major ventricular arrhythmias and no clinical signs of heart failure in the group.
The main long-term concern is pulmonary regurgitation, a condition where the valve leaks backward after being opened. This is common after both balloon and surgical treatment. In mild amounts it causes no problems, but significant regurgitation creates a different kind of stress on the right ventricle: instead of pushing against a tight valve, the chamber now has to handle blood flowing backward into it with each heartbeat. Over 15 to 30 years, this volume overload can gradually stretch the right ventricle, cause the wall between the heart’s chambers to move abnormally, and in some cases lead to irregular heart rhythms originating in the upper chambers. These arrhythmias have been observed to resolve after reoperation to address the leaky valve.
Because of this slow progression, lifelong follow-up with periodic imaging is standard even after a successful procedure. The goal is to catch any worsening regurgitation or right ventricular changes early, long before they cause symptoms or lasting damage.